Zhiyun Health and Sanofi China Launch Strategic Partnership to Advance Digital Chronic Disease Management and Online Healthcare Innovation

In recent years, with the continuous improvement of relevant policies, regulations, and standards, various regions have strengthened guidance and increased support for exploring health services, paving a fast track for the development of “Internet + Healthcare.” However, while internet healthcare is flourishing, it still faces numerous challenges. For instance, during online consultations, doctors’ limited time and energy often result in prolonged response times or lack of targeted advice, thereby compromising patients’ consultation experience. In terms of online medication purchases, issues such as inadequate insurance coverage and patient concerns about medication safety and therapeutic efficacy further diminish patients’ sense of benefit from and adherence to online medical consultations.

To address this core issue, Zhiyun Health and Sanofi China initiated a strategic partnership on the afternoon of July 13. By leveraging their respective strengths, the two parties will jointly develop an integrated “Internet+” chronic disease management model that spans in-hospital and out-of-hospital settings as well as online and offline channels, tailored to China’s national conditions and focused on industry needs. This collaboration aims to cover more scenarios and serve more users, thereby creating favorable conditions for the digital transformation and upgrading of chronic disease management and enhancing public well-being.

Under this strategic collaboration, both parties will leverage advanced concepts in chronic disease management to build a physician education platform and innovate educational content. This initiative aims to enhance physicians’ understanding of medication standards and efficacy evaluation, enabling them to access practical prescribing information anytime and anywhere based on daily clinical needs. By improving the level of rational clinical drug use, the collaboration seeks to provide higher-quality diagnostic and therapeutic services for patients. Meanwhile, by relying on online medical platforms and an efficient supply chain, patients can obtain integrated solutions for chronic disease prevention, treatment, rehabilitation, and follow-up care at their convenience. This approach facilitates precise connectivity and matching among physicians, patients, and pharmaceuticals, thereby enhancing the patient experience throughout the entire journey of chronic disease management.

Dr. Pius S. Hornstein, President of Sanofi Greater China, stated that the Outline of the 14th Five-Year Plan proposes to “build a Digital China.” In the field of digital healthcare, Sanofi’s objectives are highly aligned with those of the Chinese government. As a pioneer in digital healthcare, Sanofi has consistently collaborated with industry partners to explore innovations in internet-based healthcare, leveraging technology to empower the health and medical ecosystem and using digitalization to help a broader patient population revitalize their lives. This deep strategic cooperation with Zhiyun Health once again underscores Sanofi’s unwavering commitment to improving the health of the Chinese people through an innovative healthcare ecosystem.

Mr. Kuang Ming, Founder and CEO of Zhiyun Health, stated that Zhiyun Health is committed to empowering participants across the healthcare value chain through digital innovation, thereby contributing to the Healthy China initiative. Leveraging Sanofi’s extensive expertise in the medical field, combined with Zhiyun Health’s accumulated achievements in digital chronic disease management and its profound market insights, this partnership is poised to serve as a catalyst for the rapid advancement of digital chronic disease management in China, further accelerating the development of the next-generation “Internet+ Healthcare” ecosystem.

Currently, the burden of chronic diseases in China is becoming increasingly heavy, with chronic diseases emerging as a major public health issue affecting the country’s economic and social development. According to the Healthy China Action (2019–2030), chronic diseases have become the leading cause of death and disease burden among Chinese residents, accounting for more than 70% of the total disease burden and representing a significant constraint on population health. Moreover, individuals with chronic conditions require long-term, often lifelong, follow-up visits and medication, subjecting them to substantial psychological and financial stress and resulting in a lower quality of life. Therefore, there is an urgent need to adopt more efficient and standardized management models to address the high incidence and prevalence of chronic diseases and the challenges in their prevention and control, thereby improving patients’ quality of life and enhancing their sense of well-being.

Through the joint efforts of Zhiyun Health and Sanofi China, patients with chronic diseases can access one-stop chronic disease management services—including health monitoring, online consultations, medication delivery, disease education, and health follow-ups—via an innovative whole-course medical solution that spans “prevention, diagnosis and treatment, and prognosis.” This approach effectively enhances the convenience of medical care, reduces healthcare costs, and makes high-quality medical services more accessible. Meanwhile, Zhiyun Health’s accumulation of high-quality physician resources, standardized online service protocols, and a comprehensive digital chronic disease management system will better safeguard the health of chronic disease patients, broadly benefit public welfare, and promote common prosperity.